期刊文献+

曲美他嗪对老年性缺血性扩张型心肌病的疗效观察 被引量:1

Effect of Trimetazidine on Improving Heart Function in Patients with Senile and Ischemic Dilated Cardiomyopathy
下载PDF
导出
摘要 目的观察在常规治疗的基础上加用曲美他嗪对改善老年性缺血性扩张型心肌病心力衰竭的疗效。方法将40例符合诊断标准的老年性缺血性扩张型心肌病的患者随机分为常规治疗组(对照组)和曲美他嗪治疗组(治疗组),两组疗程均为20周,比较两组治疗前后的临床疗效、心功能分级、LVEF值、心胸比等。结果曲美他嗪治疗组临床心功能分级明显改善,LVEF值显著提高,而血压、心率无影响。结论曲美他嗪治疗能明显改善老年性缺血性扩张型心肌病患者心功能。 Objective To observe the effect of trimetazidine on the patient with senile and ischemic dilated cardiomyopatby. Methods 40 patients with senile and iscbemic dilated cardiomyopatby who were randomized into conventional therapy group and trimetazidine therapy group. The treatment durations were both 20 weeks. Results Compared with that of conventional therapy group, not only the cardiac function of the trimetazidine group improved remarkdly,but also the improvement of LVEF was more significant as well. Conclusion Combined therapy of trimetazidine and conventional drugs improved the cardiac function in the patients with senile and iscbemic dilated cardiomyopatby more effectively.
出处 《中国实用医药》 2008年第4期41-42,共2页 China Practical Medicine
关键词 曲美他嗪 老年性缺血性扩张型心肌病 心功能 Trimetazidine Senile and iscbemic dilated cardiomyopatby Heart function
  • 相关文献

参考文献4

  • 1徐成斌.慢性心力衰竭治疗新理念[J].中国医刊,2003,38(11):2-4. 被引量:26
  • 2[3]LuC,Dabrowski P,Fragasso G,et al.Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease.Am J Cardiol,1998,82(7):898-901.
  • 3[4]Marzilli M.Cardioprotective effects of trimetazidine:a review.Curr Med Res Opin,2003,19 (7):661-672.
  • 4[5]Kantor P,Lucien A,Kozak R,et al.The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-term 3-ketoacyl coenzyme A thiolase.Circ Res,2000,86 (5):580-588.

共引文献25

同被引文献18

  • 1刘畅.曲美他嗪治疗冠心病心力衰竭[J].医药论坛杂志,2006,27(3):66-66. 被引量:3
  • 2Stanley WC.Metabolic therapy in the treatment of ischemic heart disease:the pharmacology of trimetazidine[J].Fun Clin Pha,2003,17(2):133-145.
  • 3Narzilli M,Klein WW.Efficacy and tolerability of trimetazidine in stable angina:a meta-analysis of randomized double-blind controlled trials[J].Coron Art Dis,2003,14(2):171.
  • 4Mc Clellan KJ,Plosker GL.Trimetazidine:A review of its use in stable angina pectoris and other coronary conditions[J].Drugs,1999,50:143-157.
  • 5Desideri A,Celegon L.Metabolic management of ischemic heart disease:clinical data with trimetazidine[J].Am J Cardiol,1998,82(5A):50K-53K.
  • 6Szwed H,Pachocki R,Domzal-Bochenska M.Efficac ité et tolérance de la trimétazidine,antiangoreux métabolique,en association avec un antiangoreux hémodynamique dans langor déffort stable[J].Presse Med,2000,29:533-538.
  • 7Rogacka D,Guzik P,Wykrεtowicz A,et al.Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X:a preliminary study[J].Coren Arterg Dis,2000,11:171-177.
  • 8Lu C,Dabrowski P,Fragasso G,et al.Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease[J].Heart,1998,82:898-901.
  • 9Manchanda SC.Krishnaswami S Combination treatment with trimetazidine and diltiazem in stable angina pectoris[J].Heart,1997,78(4):353-357.
  • 10DiNapoli P,DiGiovanni P,Gaeta MA,et al.Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy:a post hoc analysis of the Villa Pinid Abruzzo Trimetazidine Trial[J].J Cardiovasc Pharmacol,2007,50(5):585-589.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部